HFMD

Clinical trial pipeline · Data from ClinicalTrials.gov

See which HFMD trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 5 trials

RecruitingNot Applicable

NCT07008755

Clinical Trial of Pegylated Interferon α-2b Via Nebulization for Treatment of Hand, Foot, and Mouth Disease .

This is a multicenter clinical trial investigating the safety and efficacy of inhaled Peginterferon α-2b at different doses, in combination with supportive care…

China90 participantsStarted 2024-07-31

Treatment: Peginterferon α-2b injection, Peginterferon α-2b injection

RecruitingPhase 3

NCT06734832

Efficacy, Safety, and Immunogenicity of the Bivalent Inactivated Enterovirus Vaccine (Vero Cell)

This multicenter, randomized, double-blind, controlled Phase III clinical trial aims to evaluate the efficacy, safety, and immunogenicity of the bivalent entero…

China8,000 participantsStarted 2024-12-13

Treatment: bivalent enterovirus vaccine (Vero cell), inactivated, Enterovirus Type 71 Vaccine (Vero Cell), Inactivated

RecruitingNot Applicable

NCT06699433

Artificial Intelligence-driven Virtual Standardized Pediatric Patients Trial

Background: China's healthcare system for children faces significant challenges, particularly due to the limited pediatric service capacity of primary healthcar…

China459 participantsStarted 2024-12

Treatment: Virtual standardized patients (VSPs), Case teaching manuals

RecruitingNot Applicable

NCT06263439

Surveillance of HFMD in Pediatric Outpatients

The aims of this prospective multicentric study is to determine the types of enteroviruses (EVs) responsible for hand, foot and mouth disease (HFMD) or herpangi…

France3,000 participantsStarted 2023-06-20

Treatment: Throat/buccal swab sample

RecruitingPhase 4

NCT06146088

Lot-to-lot Consistency Study of Three Commercial Batches of Enterovirus 71 Vaccine

This study is a randomized, blinded study to evaluate the lot-to-lot consistency of immunogenicity, safety, and immune persistence of three consecutive manufact…

China1,500 participantsStarted 2023-11-25

Treatment: EV71 Vaccine

All recent trials (60 shown)

CompletedPhase 1/2

NCT06754384

Tolerability, Safety, and Immunogenicity of Tetravalent Inactivated Enterovirus Vaccine (Vero Cell).

The trial aims to assess the tolerability, safety, and immunogenicity of the tetravalent inactivated enterovirus vaccine in adults and children aged 6 months to…

China552 participantsStarted 2025-01-15

Treatment: Low-dose of tetravalent inactivated enterovirus vaccine (Vero cell), Medium-dose tetravalent inactivated enterovirus vaccine (Vero cell)

Active — Not RecruitingPhase 1/2

NCT06063057

Inactivated Bivalent Enterovirus Vaccine (Vero Cell) Phase I/II Clinical Trial

The Phase I clinical trial is divided into two parts. The first part uses an open-label design, while the second part uses a randomized, double-blind, and contr…

China744 participantsStarted 2023-09-20

Treatment:

HFMD

Trial phase breakdown

Trial status

Actively recruiting — 5 trials

Clinical Trial of Pegylated Interferon α-2b Via Nebulization for Treatment of Hand, Foot, and Mouth Disease .

Efficacy, Safety, and Immunogenicity of the Bivalent Inactivated Enterovirus Vaccine (Vero Cell)

Artificial Intelligence-driven Virtual Standardized Pediatric Patients Trial

Surveillance of HFMD in Pediatric Outpatients

Lot-to-lot Consistency Study of Three Commercial Batches of Enterovirus 71 Vaccine

All recent trials (60 shown)

Tolerability, Safety, and Immunogenicity of Tetravalent Inactivated Enterovirus Vaccine (Vero Cell).

Inactivated Bivalent Enterovirus Vaccine (Vero Cell) Phase I/II Clinical Trial

Trial phase breakdown

Trial status

Actively recruiting — 5 trials

Clinical Trial of Pegylated Interferon α-2b Via Nebulization for Treatment of Hand, Foot, and Mouth Disease .

Efficacy, Safety, and Immunogenicity of the Bivalent Inactivated Enterovirus Vaccine (Vero Cell)

Artificial Intelligence-driven Virtual Standardized Pediatric Patients Trial

Surveillance of HFMD in Pediatric Outpatients

Lot-to-lot Consistency Study of Three Commercial Batches of Enterovirus 71 Vaccine

All recent trials (60 shown)

Tolerability, Safety, and Immunogenicity of Tetravalent Inactivated Enterovirus Vaccine (Vero Cell).

Inactivated Bivalent Enterovirus Vaccine (Vero Cell) Phase I/II Clinical Trial

Phase I Clinical Trial of Enterovirus Type71 - Coxsackievirus Type A16 Bivalent Vaccine

Study on the Persistence of Immunity Following EV71 Vaccination

A Study to Evaluate the Efficacy, Immunogenicity and Safety of an EV71 Vaccine in Healthy Infants and Children

Propolis as a Treatment Option for Hand Foot and Mouth Disease

Hand, Foot, and Mouth Disease: Could EPs®7630 be a Treatment Option

Active Case Finding of Clinical Hand Foot Mouth Disease in Children Aged 6 Months Old to 18 Years Old in Indonesia

Immunogenicity of the Inactivated EV71 Vaccine Combined With Hepatitis B and Group A Meningococcal Vaccine

A Serosurvey Study of Hand, Foot, and Mouth Disease in Indonesia

A Safety Study of Inactivated EV71 Vaccine (Human Diploid Cell, KMB-17) in Chinese Adults, Children and Infants

A Phase II, Safety and Efficacy Study of Inactivated EV 71 Vaccine (Human Diploid Cell, KMB-17) in Chinese Infants

A Protected Study of Inactivated EV71 Vaccine (Human Diploid Cell, KMB-17) in Chinese Infants and Children

The Phase IVb of Inactivated Enterovirus 71 Vaccine (Human Diploid Cell, KMB-17) in Chinese Children

The Immunogenicity and Safety of the Vaccination of Inactivated Enterovirus 71 Vaccine and Seasonal Influenza Vaccine

Safety Observation of Enterovirus 71 Inactivated Vaccine (Vero Cell) Combined Immunization in Shanghai

An Immunity Persistence Study of Enterovirus 71 Inactivated Vaccine (Vero Cell)

A Follow-up Study for a Phase III, Efficacy Trial in Inactivated Enterovirus Type 71 (EV71) Vaccine

Clinical Trial of Enterovirus 71（EV71） Inactivated Vaccine in Children Aged 36-71 Months

Sucralfate to Improve Oral Intake in Children With Infectious Oral Ulcers: a Randomized, Double-blind, Placebo-Controlle…